Live feed00:30:00·2dPRReleasevia QuantisnowJazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share RepurchasesByQuantisnow·Wall Street's wire, on your screen.JAZZ· Jazz Pharmaceuticals plcHealth Care